Literature DB >> 1625069

Impairment of lung diffusion capacity in Schönlein-Henoch purpura.

M Chaussain1, D de Boissieu, G Kalifa, S Epelbaum, P Niaudet, J Badoual, D Gendrel.   

Abstract

Twenty-nine children with typical Schönlein-Henoch purpura (SHP) were tested at the initial phase of the disease for respiratory function. Of the 29 patients, 28 had a decrease of lung transfer for carbon monoxide (TLCO) as measured by a steady-state method. Lung volumes and blood gas values were normal; slight radiologic signs of interstitial lung involvement were observed in 18 of 26 patients. There was a decrease in TLCO to 56.8% of normal values for height and gender and to 58.5% when normal values were volume-adjusted to functional residual capacity. In 19 of 25 patients, TLCO measurements were performed at 3-month intervals during follow-up. In all cases, normalization of TLCO values was observed only after complete clinical recovery from SHP. All children with persisting symptoms, even limited to microscopic hematuria or slight proteinuria, had low TLCO values. In one patient low TLCO during follow-up preceded a late relapse of SHP in the form of acute nephritic disease with characteristic IgA deposits on renal biopsy. We conclude that low TLCO in SHP is probably related to alteration of the alveolar-capillary membrane by circulating immune complexes. This noninvasive technique may be useful in diagnosis, and during the follow-up of the disease as an early indicator of reactivation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1625069     DOI: 10.1016/s0022-3476(05)82533-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  15 in total

Review 1.  Henoch-Schönlein purpura.

Authors:  E J Tizard
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

Review 2.  Multisystemic manifestations of IgA vasculitis.

Authors:  Lina Du; Panpan Wang; Chang Liu; Shaojing Li; Shuang Yue; Yan Yang
Journal:  Clin Rheumatol       Date:  2020-06-16       Impact factor: 2.980

3.  Henoch-Schönlein purpura: a case with atypical presentation.

Authors:  Mukaddes Kalyoncu; Murat Cakir; Erol Erduran; Aysenur Okten
Journal:  Rheumatol Int       Date:  2005-09-23       Impact factor: 2.631

4.  Pulmonary hemorrhage in an adolescent with Henoch-Schönlein purpura.

Authors:  E R Carter; J P Guevara; D R Moffitt
Journal:  West J Med       Date:  1996-02

5.  The absence of anti-neutrophil cytoplasmic antibodies in patients with Henoch-Schönlein purpura.

Authors:  W L Robson; A K Leung; R C Woodman
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

6.  Alteration of lung diffusion capacity in IgA nephropathy.

Authors:  S Ravilly; M Chaussain; J L Iniguez; A Lenhert; G Kalifa; P Brun; P Niaudet; D Gendrel
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

7.  No impairment of pulmonary function in children with Henoch-Schonlein purpura after 4-year follow-up.

Authors:  Izabela Grabska-Kobylecka; Dariusz Nowak; Anna Wlodarczyk; Piotr Bialasiewicz
Journal:  Clin Rheumatol       Date:  2016-07-27       Impact factor: 2.980

Review 8.  Henoch-Schönlein purpura.

Authors:  Abraham Gedalia
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

9.  Possible pathogenic role of IgE in Henoch-Schönlein purpura.

Authors:  J C Davin; G Pierard; C Dechenne; D Grossman; J Nagy; M Quacoe; M Malaise; M Hall; F Jansen; J M Chantraine
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

10.  Pulmonary hemorrhage associated with Henoch-Schönlein purpura in a child.

Authors:  Rie Matsubayashi; Tadashi Matsubayashi; Naoya Fujita; Takuya Yokota; Yoichiro Ohro; Hideo Enoki
Journal:  Clin Rheumatol       Date:  2008-01-15       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.